Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
University of Montreal
Montreal, CanadáPublicaciones en colaboración con investigadores/as de University of Montreal (14)
2024
2023
2020
-
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
-
The Smc5/6 Core Complex Is a Structure-Specific DNA Binding and Compacting Machine
Molecular Cell, Vol. 80, Núm. 6, pp. 1025-1038.e5
2019
-
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology, Vol. 6, Núm. 9, pp. e448-e458
2018
-
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
The Lancet, Vol. 391, Núm. 10137, pp. 2325-2334
2016
-
Centrosome-Dependent Bypass of the DNA Damage Checkpoint by the Polo Kinase Cdc5
Cell Reports, Vol. 14, Núm. 6, pp. 1422-1434
-
Checkpoint adaptation: Keeping Cdc5 in the T-loop
Cell Cycle
2014
-
Consensus guidelines for the detection of immunogenic cell death
OncoImmunology, Vol. 3, Núm. 9
-
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 11, pp. 1195-1206
-
The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: A meta-analysis in patients with cancer
Pharmacogenomics Journal, Vol. 14, Núm. 2, pp. 115-119
2012
-
Restricciones físicas en UCI: su utilización y percepción de pacientes y familiares
Enfermeria Intensiva, Vol. 23, Núm. 2, pp. 77-86
2010
-
La calidad asistencial en cuidados intensivos evaluada por los pacientes mediante la escala SERVQUAL
Enfermeria Intensiva, Vol. 21, Núm. 1, pp. 3-10